ロード中...
In vitro activity of Bay v 3522, a new cephalosporin, compared with activities of other agents.
The in vitro activity of Bay v 3522, a new aminobenzothiazol cephem, was compared with those of other oral beta-lactams. Bay v 3522 displayed high activity against Staphylococcus spp. (MICs for 90% of strains tested [MIC90S], 0.5 micrograms/ml), Streptococcus pneumoniae (MIC90, 0.06 micrograms/ml),...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1990
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC171697/ https://ncbi.nlm.nih.gov/pubmed/2360820 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|